Betta Pharmaceuticals Hits Day High with Strong 4.58% Intraday Surge

Betta Pharmaceuticals Co., Ltd. has shown significant activity today, gaining 4.58% as of June 9, 2026. The stock reached an intraday high of CNY 52.49, marking a notable performance against the backdrop of the China Shanghai Composite, which increased by 1.28% on the same day. In terms of performance metrics, Betta Pharmaceuticals has demonstrated a 5.83% increase over the past week, contrasting with a decline of 1.6% in the broader market. However, the stock's performance over the past month reflects a slight decrease of 0.56%, while it has achieved a year-to-date gain of 9.55%, outperforming the China Shanghai Composite's 1.04% increase. Despite these short-term gains, the company has faced challenges over the longer term, with a 19.03% decline over the past year and a significant 54.62% drop over the past five years. The stock's current valuation metrics include a P/E ratio of 52.00 and a return on equity of 5.72%, indicating a high valuation relative to its earnings. The company's market capitalization stands at CNY 20,232 million, categorizing it as a large-cap entity within the pharmaceuticals and biotechnology industry.